340
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Patterns of comorbidity and psychopharmacology in adults with intellectual disability and attention deficit hyperactivity disorder: an UK national cross-sectional audit

, , , , , , ORCID Icon & ORCID Icon show all
Pages 1071-1078 | Received 22 Aug 2020, Accepted 11 Jan 2021, Published online: 24 Jan 2021

References

  • Ollendick TH, Jarrett MA, Grills-Taquechel AE, et al. Comorbidity as a predictor and moderator of treatment outcome in youth with anxiety, affective, attention deficit/hyperactivity disorder, and oppositional/conduct disorders. Clin Psychol Rev. 2008;28(8):1447–1471.
  • Barkley RA, Peters H. The earliest reference to ADHD in the medical literature? Melchior Adam Weikard’s description in 1775 of “attention deficit” (mangel der Aufmerksamkeit, Attentio Volubilis). J Atten Disord. 2012;16(8):623–630.
  • Perera B, Courtenay K. ADHD and challenging behaviour in people with intellectual disability: should we screen for ADHD? Psychiatr Danub. 2017;29(Suppl 3):562–564.
  • Perera B. Attention deficit hyperactivity disorder in people with intellectual disability. Ir J Psychol Med. 2018;35(3):213–219.
  • Rose E, Bramham J, Young S, et al. Neuropsychological characteristics of adults with comorbid ADHD and borderline/mild intellectual disability. Res Dev Disabil. 2009;30(3):496–502.
  • Al‐Khudairi R, Perera B, Solomou S, et al. Adults with intellectual disability and attention deficit hyperactivity disorder: clinical characteristics and medication profiles. Br J Lear Disabil. 2019;47(2): 145–152. .
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. Arlington: American Psychiatric Publishing; 2013.
  • Thapar A, Cooper M, Rutter M. Neurodevelopmental disorders. Lancet Psychiatry. 2017;4(4):339–346.
  • Cooper SA, Smiley E, Morrison J, et al. Mental ill-health in adults with intellectual disabilities: prevalence and associated factors. Br J Psychiatry. 2007;190(1):27–35.
  • Hughes-McCormack LA, Rydzewska E, Henderson A, et al. Prevalence of mental health conditions and relationship with general health in a whole-country population of people with intellectual disabilities compared with the general population. BJPsych Open. 2017;3(5):243–248.
  • Polanczyk G, Rohde LA. Epidemiology of attention-deficit/hyperactivity disorder across the lifespan. Curr Opin Psychiatry. 2007;20(4):386–392.
  • Simon V, Czobor P, Bálint S, et al. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry. 2009;194(3):204–211.
  • Polanczyk G, De Lima MS, Horta BL, et al. The worldwide prevalence of ADHD: A systematic review and metaregression analysis. Am J Psychiatry. 2007;164(6):942–948.
  • Fayyad J, De Graaf R, Kessler R, et al. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry. 2007;190(5):402–409.
  • Emerson E. Prevalence of psychiatric disorders in children and adolescents with and without intellectual disability. J Intellect Disabil Res. 2003;47(1):51–58.
  • Simonoff E, Pickles A, Wood N, et al. ADHD symptoms in children with mild intellectual disability. J Am Acad Child Adolesc Psychiatry. 2007;46(5):591–600.
  • Voigt RG, Barbaresi WJ, Colligan RC, et al. Developmental dissociation, deviance, and delay: occurrence of attention‐deficit‐hyperactivity disorder in individuals with and without borderline‐to‐mild intellectual disability. Dev Med Child Neurol. 2006;48(10):831–835.
  • Baker BL, Neece CL, Fenning RM, et al. Mental disorders in five-year-old children with or without developmental delay: focus on ADHD. J Clin Child Adolesc Psychol. 2010;39(4):492–505.
  • Neece CL, Baker BL, Crnic K, et al. Examining the validity of ADHD as a diagnosis for adolescents with intellectual disabilities: clinical presentation. J Abnorm Child Psychol. 2013;41(4):597–612.
  • Perera B, Audi S, Solomou S, et al. Mental and physical health conditions in people with intellectual disabilities: comparing local and national data. Br J Learn Disabil. 2020;48(1):19–27. .
  • Lowe K, Allen D, Jones E, et al. Challenging behaviours: prevalence and topographies. J Intellect Disabil Res. 2007;51(8):625–636.
  • Ahuja A, Martin J, Langley K, et al. Intellectual disability in children with attention deficit hyperactivity disorder. J Pediatr. 2013;163(3):890–895.
  • Xenitidis K, Paliokosta E, Rose E, et al. ADHD symptom presentation and trajectory in adults with borderline and mild intellectual disability. J Intellect Disabil Res. 2010;54(7):668–677.
  • Kolias AG, Cowie CJ, Tarnaris A, et al. Proposal for a British neurosurgical trainee research collaborative. Br J Neurosurg. 2012;26(3):434–435.
  • Dowswell G, Bartlett DC, Futaba K, et al. How to set up and manage a trainee-led research collaborative. BMC Med Educ. 2014;14(1):1–6.
  • Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–381.
  • Willcutt EG. The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review. Neurotherapeutics. 2012;9(3):490–499.
  • Fayyad J, Sampson NA, Hwang I, et al. The descriptive epidemiology of DSM-IV adult ADHD in the world health organization world mental health surveys. ADHD Atten Def Hyp Disord. 2017;9(1):47–65.
  • Sheehan R, Hassiotis A, Walters K, et al. Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study. BMJ. 2015;351:h4326.
  • McQuire C, Hassiotis A, Harrison B, et al. Pharmacological interventions for challenging behaviour in children with intellectual disabilities: a systematic review and meta-analysis. BMC Psychiatry. 2015;15(1):303.
  • Clark T, Feehan C, Tinline C, et al. Autistic symptoms in children with attention deficit-hyperactivity disorder. Eur Child Adolesc Psychiatry. 1999;8(1):50–55.
  • Williams NM, Zaharieva I, Martin A, et al. Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. Lancet. 2010;376(9750):1401–1408.
  • Reichow B, Volkmar FR, Bloch MH. Systematic review and meta-analysis of pharmacological treatment of the symptoms of attention-deficit/hyperactivity disorder in children with pervasive developmental disorders. J Autism Dev Disord. 2013;43(10):2435–2441.
  • Bowring DL, Totsika V, Hastings RP, et al. Challenging behaviours in adults with an intellectual disability: a total population study and exploration of risk indices. Br J Clin Psychol. 2017;56(1):16–32.
  • Shaw M, Hodgkins P, Caci H, et al. A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment. BMC Med. 2012;10:99.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.